SCHEMBL30775573

SCHEMBL30775573

Cc1cc(N)ccc1Oc1ccc2ccn(C)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.49
CYP2A6 P11509 1/20 0.39
HTR6 P50406 1/20 0.39
PIK3CB P42338 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
ALOX15 P16050 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR2A P28223 2/20 0.35
SLC6A4 P31645 1/20 0.35
BRPF1 P55201 1/20 0.34
HTR2C P28335 1/20 0.33
ROCK1 Q13464 1/20 0.33
GAA P10253 1/20 0.33
RCE1 Q9Y256 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26697735 1.00 PRKCI (0.49) PRKCICYP2A6HTR6PIK3CBL3MBTL1
SCHEMBL22076877 0.83 TFPI2 (0.38) PRKCIHTR6ALDH1A1KDM4E
SCHEMBL398452 0.78 PRKCI (0.70) PRKCICYP2A6HTR6PIK3CBL3MBTL1
SCHEMBL5718697 0.78 PRKCI (0.70) PRKCICYP2A6HTR6PIK3CBL3MBTL1
SCHEMBL29507010 0.78 PRKCI (0.70) PRKCICYP2A6HTR6PIK3CBL3MBTL1
SCHEMBL2992329 0.78 ALDH1A1 (0.52) ALDH1A1KDM4EMEN1LMNAMAPT
SCHEMBL26697740 0.78 ALDH1A1 (0.43) CYP2A6ALDH1A1KDM4EMEN1LMNA
SCHEMBL22076838 0.77 KDR (0.36) PRKCIHTR6PIK3CBKDREGFR
SCHEMBL28286771 0.77 GAA (0.57) CYP2A6ALDH1A1MEN1LMNAMAPT
SCHEMBL24168132 0.77 BRD4 (0.38) PRKCIL3MBTL1ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118459485-A Amino-substituted heterocycles for the treatment of cancers with EGFR mutations 纽威伦特公司 2024-08-09 CN disclosed
CN-117500803-A Amino-substituted heterocycles for the treatment of cancers with EGFR mutations 纽威伦特公司 2024-02-02 CN disclosed